Tom Shrader

Equity Research Analyst at BTIG

Role
Equity Research Analyst at BTIG
Location
Berkeley, CA, US
LinkedIn followers
500 followers
Finance & AccountingView LinkedIn profile

Experience

  1. Equity Research Analyst

    BTIG

    Jul 2018 — Present

    Coverage focus in complex therapeutics - ADCs, bi-mAbs, ASOs, PNAsCoverage increasingly involves the new neurodegeneration - LARRK2, TREM2, CD33Coverage includes relevant gene therapy and non-oncology cell therapy

Education

  • University of Virginia

    Biomedical Engineering Department

    1982 — 1984

  • Massachusetts Institute of Technology

    Helen Hay Whitney Postdoctoral Fellow

    1991 — 1992

  • The Johns Hopkins University

    Bachelor of Science - BS, Biophysics

  • Yale University

    PhD, Molecular Biophysics and Biochemistry

    1985 — 1990

Skills

  • Biotechnology
  • Lifesciences
  • Strategy
  • Venture Capital
  • Management

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Tom Shrader — Equity Research Analyst at BTIG in Berkeley, CA, US | Unifers